Ligand · 406
406 · N-[3-(4,5'-bipyrimidin-2-ylamino)-4-methylphenyl]-4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]methyl}-3-(trifluoromethyl) benzamide
406, N-[3-(4,5'-bipyrimidin-2-ylamino)-4-methylphenyl]-4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]methyl}-3-(trifluoromethyl) benzamide (C30 H31 F3 N8 O, 576.6 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry).…
- Component
- 406
- Formula
- C30 H31 F3 N8 O
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
406 in 2 structures; the first of them:
- 2E2B · Crystal structure of the c-Abl kinase domain in complex with INNO-406 · 406 A1001 · binds LEU248, TYR253, VAL256, ALA269, VAL270, LYS271, GLU286, VAL289 and 20 more
- 2E2B · Crystal structure of the C-abl kinase domain in complex with inno-406 · 406 A1001 · binds LEU248, TYR253, VAL256, ALA269, VAL270, LYS271, GLU286, VAL289 and 20 more
Residues it binds most
VAL 4, LEU 4, ILE 4, PHE 4, ALA 4, GLU 4, MET 4, ARG 4, ASP 4, GLY 4 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.